Global Dental Surgical Equipment Market Expands on Rising Oral Disease Burden According to a newly published market research report by 24LifeSciences, global dental surgical equipment market was valued at USD 5,808 million in 2024 and is projected to reach USD 7,727 million by 2031, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025-2031. Dental surgical equipment comprises the specialized instruments and devices used for the diagnosis, surgical intervention, and treatment of oral diseases and conditions. This includes a wide array of products from diagnostic imaging systems and lasers to therapeutic instruments, delivery systems, and surgical handpieces. These tools are essential for procedures ranging from routine tooth extractions to complex dental implantology and maxillofacial surgeries, forming the backbone of modern oral healthcare delivery. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9104/dental-surgical-equipment-market

What Is the Future of the Dental Electrosurgical Generators Market? Growth Insights According to a newly published market research report by 24LifeSciences, global dental surgery electrosurgical generators market was valued at USD 285 million in 2024 and is projected to reach USD 425 million by 2032, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period. Dental surgery electrosurgical generators are advanced medical devices that produce high-frequency electrical currents for cutting, coagulating, desiccating, and fulgurating tissues during dental procedures. These systems are indispensable in modern dentistry, enabling precise soft tissue management with minimized bleeding and enhanced surgical visibility. Available in monopolar and bipolar configurations, they are essential tools for procedures ranging from gingivectomies to implantology, supporting both routine and complex oral surgeries. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10136/dental-surgery-electrosurgical-generators-market

Tissue Sealants and Adhesives Market to Reach USD 7.26 Billion by 2032 | Trends & Forecast According to a newly published market research report by 24LifeSciences, global tissue sealants and tissue adhesive market was valued at USD 4.12 billion in 2024 and is projected to reach USD 7.26 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period 2025–2032. Tissue sealants and adhesives are advanced biomaterials used to achieve hemostasis and approximate wound edges, effectively replacing or supplementing traditional sutures and staples. These products function by creating a barrier or bond that promotes natural healing while preventing fluid or air leakage from tissues and organs. Major product categories include fibrin sealants, collagen-based sealants, synthetic adhesives like cyanoacrylates, and albumin-based glues, each designed for specific surgical applications across cardiovascular, orthopedic, and general surgery. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10358/tissue-sealants-and-tissue-adhesive-market

FibroTouch Devices Market Size to Reach USD 220 Million by 2032 | Growth Insights Global FibroTouch Devices market is undergoing steady expansion as healthcare systems increasingly prioritize non-invasive diagnostics for liver disease management. Valued at USD 120 million in 2024, the market is projected to grow from USD 132 million in 2025 to USD 220 million by 2032, registering a CAGR of 7.8% during the forecast period. This growth reflects a structural shift away from invasive liver biopsies toward faster, safer, and more patient-friendly elastography-based solutions that deliver real-time clinical insights. The FibroTouch Devices market is gaining prominence across hospitals, diagnostic centers, and specialty clinics as chronic liver conditions such as NAFLD, viral hepatitis, and alcoholic liver disease continue to rise globally. Increasing disease awareness, early screening initiatives, and technological refinements are positioning FibroTouch as a core diagnostic modality in modern hepatology workflows. Access the market report https://www.24lifesciences.com/fibrotouch-devices-market-9969

Tardive Dyskinesia Treatment Market Size to Reach USD 1.3 Billion by 2032 | Growth Insights Global Tardive Dyskinesia Treatment market is undergoing a notable transformation as healthcare systems prioritize early diagnosis, neurological specialization, and precision pharmacotherapy. Valued at USD 643.5 million in 2024, the market is projected to grow from USD 720.6 million in 2025 to USD 1.3 billion by 2032, expanding at a CAGR of 9.2% during the forecast period. Rising awareness of movement disorders, increased use of long-term antipsychotic therapies, and the growing adoption of FDA-approved VMAT2 inhibitors are central to this sustained growth trajectory. Access the market report https://www.24lifesciences.com/tardive-dyskinesia-treatment-market-10341

Oral Flat Panel Detector Market Size to Reach USD 560 Million by 2032 | Dental Imaging Trends Global oral flat panel detector market is witnessing steady expansion as digital dentistry becomes a core component of modern oral healthcare. Valued at approximately USD 320 million in 2024, the market is expected to grow from USD 345 million in 2025 to USD 560 million by 2032, registering a compound annual growth rate (CAGR) of around 7.2% during the forecast period. This growth is driven by the rapid replacement of analog imaging systems, rising demand for high-resolution diagnostics, and increasing adoption of advanced dental technologies across clinical settings. Access the complete report https://www.24lifesciences.com/oral-flat-panel-detector-market-9920

Facial Paralysis Treatment Market Size to Reach USD 3.4 Billion by 2032 | Growth Forecasts & Insights Global facial paralysis treatment market is witnessing strong momentum as healthcare systems increasingly prioritize neurological rehabilitation, early intervention, and functional recovery. Valued at USD 1.8 billion in 2024, the market is expected to expand from USD 1.95 billion in 2025 to USD 3.4 billion by 2032, registering a robust CAGR of 7.2% during the forecast period. This growth reflects rising disease awareness, advances in medical therapies and surgical techniques, and growing demand for comprehensive, multidisciplinary care models. Access the complete report https://www.24lifesciences.com/facial-paralysis-treatment-market-9209

Circulating Tumor Cell Detector Market Size to Reach USD 15.1 Billion by 2032 | Growth Insights Global circulating tumor cell detector market is undergoing a pivotal transformation as oncology care shifts toward non-invasive, precision-driven diagnostics. Valued at USD 7.2 billion in 2024, the market is projected to grow from USD 7.9 billion in 2025 to USD 15.1 billion by 2032, expanding at a CAGR of 9.4% during the forecast period. This sustained growth reflects the rising global cancer burden and the increasing clinical reliance on liquid biopsy technologies to guide diagnosis, prognosis, and treatment monitoring. Access the complete report https://www.24lifesciences.com/circulating-tumor-cell-detector-market-10059

Multiple Sclerosis Treatment Market Size to Reach USD 19.1 Billion by 2032 | Growth Global multiple sclerosis treatment market is undergoing steady clinical and commercial evolution as healthcare systems prioritize early diagnosis, disease modification, and long-term neurological care. Valued at USD 16.5 billion in 2024, the market is projected to grow from USD 16.9 billion in 2025 to USD 19.1 billion by 2032, registering a CAGR of 2.2% over the forecast period. This measured growth reflects the maturity of established therapies alongside continuous innovation in high-efficacy disease-modifying treatments (DMTs). Access the complete report https://www.24lifesciences.com/multiple-sclerosis-treatment-market-9542

Peptide and Heparin Market Size to Reach USD 58.9 Billion by 2031 | Growth Insights Global peptide and heparin market is undergoing steady and strategic expansion, supported by rising demand for advanced biologic therapies and critical anticoagulation treatments. Valued at USD 42.5 billion in 2024, the market is projected to reach USD 58.9 billion by 2031, growing at a CAGR of 4.8% during the forecast period. This growth reflects the increasing clinical reliance on peptide-based drugs and heparin across cardiovascular care, oncology, and metabolic disorder management worldwide. Access the complete report https://www.24lifesciences.com/peptide-and-heparin-market-9010